Intrinsiqq
Pediatrix Medical Group, Inc. logo

Pediatrix Medical Group, Inc. (MD) Insider Trading

Last 12 months

Insiders sold $1.83M and bought nothing on the open market.

None of the selling was scheduled in advance under a 10b5-1 plan. Director Shirley A Weis sold $856k on May 13, 66% of their stake, outside a plan. The last open-market buy by an executive or director was in Aug 2019.

Net open-market
−$1.83M
0 buys · 4 sales
Under a 10b5-1 plan
0%
of the value sold
Insiders who bought / sold
0 / 4
executives and directors
Last open-market buy
Aug 2019
Aug 12, 2019

Get an email when MD's executives or directors buy, or make a large sale outside a plan.

Trades · last 2 years

  • May 13No plan
    Shirley A Weis
    Director · sold 36,028 at $23.75
    $856k
    66% of stake
  • Dec 15, 2025No plan
    Mark S Ordan
    Chief Executive Officer · sold 23,000 at $22.41
    $515k
    7.1% of stake
  • Nov 17, 2025No plan
    Michael A. Rucker
    Director · sold 10,478 at $23.00
    $241k
    15% of stake
  • Nov 6, 2025No plan
    Laura A Linynsky
    Director · sold 10,000 at $21.65
    $217k
    24% of stake
  • Nov 13, 2024No plan
    Mark S Ordan
    Director · sold 27,600 at $15.35
    $424k
    17% of stake
  • Nov 8, 2024No plan
    Mary Ann E Moore
    EVP, GC, Chief Admin Off & Sec · sold 8,108 at $16.00
    $130k
    5.1% of stake
How to read this. Insiders sell for many reasons: taxes, diversifying, a house. Open-market buys are rarer and say more. A 10b5-1 plan is a trading schedule set up months in advance, so those sales were not timed on news. Large holders (funds and 10% owners) are listed under Everything but not counted as insiders. If you own or watch MD, we send a push when an executive buys or makes a large sale outside a plan.

Source: SEC Form 4 filings, filed within two business days of each trade and checked for new ones every hour.

Related stocks: Services-Hospitals

Spot a number that looks wrong? Check it in MD's SEC filings or

Download this analysis as a PDF (Pro)

Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.

2 of 2 free stocks used today

Keep analysing MD

Create a free account and get 14 days of Premium: every stock and every tool.

  • Unlimited stocks
  • Stock screener
  • Portfolio tracker
  • Editable DCF
  • Compare side by side
  • Unlimited alerts

No card. Moves to Free after, unless you upgrade.

Already have an account?

Or come back tomorrow. Stocks on your watchlist are always free to view.

SectorsPrivacyTerms© 2026 Intrinsiqq

Not financial advice. Analytical data for research only.

Intrinsiqq is a Netherlands-based company operating in Rotterdam, KvK 73238007.